EUVIMEDEUVIMED entdecken
BeobachtungsstudieVergleichsstudie

PCI Versus Conservative Management Before TAVR in Patients With Significant Coronary Artery Disease: A Nationwide Instrumental Variable Analysis

Antros Louca iD, Petur Petursson iD, Joakim Sundström iD, Henrik Hagström, Andreas Rück iD, Stefan James iD, Sasha Koul, Kristofer Skoglund iD, Mohammed Mohammed iD, Anders Jeppsson iD, Dan Ioanes iD, Sebastian Völz iD und 4 weitere

Circulation: Cardiovascular Interventions · 2026-04 · 19 (4)

DOI: 10.1161/circinterventions.125.016337 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Circulation: Cardiovascular Interventions, 2026-04. Verfasst von Antros Louca und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology (A.L., P.P., J.S., K.S., M.M., D.I., S.V., A.M., O.A., A. Rawshani, T.R.), Sahlgrenska University Hospital, Gothenburg, Swed…. Hauptthemen laut MEDLINE: Conservative Treatment, Percutaneous Coronary Intervention, Transcatheter Aortic Valve Replacement, Coronary Artery Disease. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The optimal management of coronary artery disease in patients undergoing transcatheter aortic valve replacement (TAVR) remains unclear, and evidence supporting routine percutaneous coronary intervention (PCI) beforehand is limited. This study aimed to evaluate whether PCI before TAVR provides clinical benefit compared with conservative management in patients with significant coronary artery disease, using nationwide Swedish registry data. METHODS: This observational study included 2578 Swedish patients with significant coronary artery disease (≥50% angiographic stenosis or physiologically significant lesions) who underwent TAVR between 2008 and 2023. 1182 underwent PCI before TAVR, and 1396 were managed conservatively. The primary outcome was a composite of all-cause mortality, myocardial infarction, and urgent revascularization. Secondary outcomes included the individual components, cardiovascular mortality, any revascularization, stroke, and bleeding. The primary analysis used an instrumental variable approach based on each region’s quarterly PCI treatment preference to account for confounding. RESULTS: PCI was not associated with a significant difference in the primary composite outcome (instrumental variable–adjusted hazard ratio, 0.98 [95% CI, 0.85–1.14]; P =0.80) or in all-cause mortality, myocardial infarction, cardiovascular death, stroke, or urgent revascularization. PCI was, however, associated with a lower risk of any revascularization (adjusted hazard ratio, 0.46 [95% CI, 0.30–0.72]; adjusted P =0.002) and a higher risk of bleeding (instrumental variable–adjusted odds ratio, 1.59 [95% CI, 1.23–2.04]; adjusted P =0.002). CONCLUSIONS: In this nationwide cohort, PCI before TAVR did not improve survival or reduce urgent revascularization but did reduce nonurgent revascularization at the cost of increased bleeding. Decisions should be individualized, balancing ischemic and bleeding risks and considering anticipated coronary access after TAVR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Conservative TreatmentPercutaneous Coronary InterventionTranscatheter Aortic Valve ReplacementCoronary Artery DiseaseAortic Valve StenosisHumansMaleFemaleAged, 80 and overRegistriesTreatment OutcomeSwedenRisk FactorsTime FactorsRisk AssessmentAged

Stichwörter der Autor:innen

Swedencoronary artery diseasemyocardial infarctionpercutaneous coronary interventiontranscatheter aortic valve replacement

Autor:innen und Institutionen

  • Department of Cardiology (A.L., P.P., J.S., K.S., M.M., D.I., S.V., A.M., O.A., A. Rawshani, T.R.), Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Department of Molecular and Clinical Medicine, Institute of Medicine, University of Gothenburg, Sweden (A.L., P.P., J.S., K.S., M.M., A.J., D.I., S.V., A.M., O.A., A. Rawshani, T.R.).
  • Heart Centre, Umeå University Hospital, Sweden (H.H.).
  • Department of Public Health and Clinical Medicine, Umeå University, Sweden (H.H.).
  • Department of Cardiology, Karolinska University Hospital and Karolinska Institute, Stockholm, Sweden (A. Rück).
  • Department of Medical Sciences, Cardiology, Uppsala University, Sweden (S.J.).

ORCID-Profile: Antros Louca, Petur Petursson, Joakim Sundström, Andreas Rück, Stefan James, Kristofer Skoglund, Mohammed Mohammed, Anders Jeppsson, Dan Ioanes, Sebastian Völz, Anna Myredal, Oskar Angerås

Zitieren

APA

Louca, A., Petursson, P., Sundström, J., Hagström, H., Rück, A., James, S., Koul, S., Skoglund, K., Mohammed, M., Jeppsson, A., Ioanes, D., Völz, S., Myredal, A., Angerås, O., Rawshani, A., & Råmunddal, T. (2026). PCI Versus Conservative Management Before TAVR in Patients With Significant Coronary Artery Disease: A Nationwide Instrumental Variable Analysis. Circulation: Cardiovascular Interventions, 19(4). https://doi.org/10.1161/circinterventions.125.016337

Vancouver

Louca A, Petursson P, Sundström J, Hagström H, Rück A, James S, et al. PCI Versus Conservative Management Before TAVR in Patients With Significant Coronary Artery Disease: A Nationwide Instrumental Variable Analysis. Circulation: Cardiovascular Interventions. 2026;19(4). doi:10.1161/circinterventions.125.016337

BibTeX
@article{Louca2026,
  author = {Louca, Antros and Petursson, Petur and Sundström, Joakim and Hagström, Henrik and Rück, Andreas and James, Stefan and Koul, Sasha and Skoglund, Kristofer and Mohammed, Mohammed and Jeppsson, Anders and Ioanes, Dan and Völz, Sebastian and Myredal, Anna and Angerås, Oskar and Rawshani, Araz and Råmunddal, Truls},
  title = {PCI Versus Conservative Management Before TAVR in Patients With Significant Coronary Artery Disease: A Nationwide Instrumental Variable Analysis},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2026},
  volume = {19},
  number = {4},
  doi = {10.1161/circinterventions.125.016337}
}
Kostenlos starten →